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Abstract
Objectives: Binge drinking and alcohol toxicity are often associated with myocardial dysfunction possibly due to
accumulation of the ethanol metabolite acetaldehyde although the underlying mechanism is unknown. This study was
designed to examine the impact of accelerated ethanol metabolism on myocardial contractility, mitochondrial function and
apoptosis using a murine model of cardiac-specific overexpression of alcohol dehydrogenase (ADH).
Methods: ADH and wild-type FVB mice were acutely challenged with ethanol (3 g/kg/d, i.p.) for 3 days. Myocardial
contractility, mitochondrial damage and apoptosis (death receptor and mitochondrial pathways) were examined.
Results: Ethanol led to reduced cardiac contractility, enlarged cardiomyocyte, mitochondrial damage and apoptosis, the
effects of which were exaggerated by ADH transgene. In particular, ADH exacerbated mitochondrial dysfunction manifested
as decreased mitochondrial membrane potential and accumulation of mitochondrial O2
N2. Myocardium from ethanol-
treated mice displayed enhanced Bax, Caspase-3 and decreased Bcl-2 expression, the effect of which with the exception of
Caspase-3 was augmented by ADH. ADH accentuated ethanol-induced increase in the mitochondrial death domain
components pro-caspase-9 and cytochrome C in the cytoplasm. Neither ethanol nor ADH affected the expression of ANP,
total pro-caspase-9, cytosolic and total pro-caspase-8, TNF-a, Fas receptor, Fas L and cytosolic AIF.
Conclusions: Taken together, these data suggest that enhanced acetaldehyde production through ADH overexpression
following acute ethanol exposure exacerbated ethanol-induced myocardial contractile dysfunction, cardiomyocyte
enlargement, mitochondrial damage and apoptosis, indicating a pivotal role of ADH in ethanol-induced cardiac dysfunction
possibly through mitochondrial death pathway of apoptosis.
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Introduction
Alcohol (ethanol) exposure often results in the development of
alcoholic cardiomyopathy characterized by cardiomegaly (dilated
cardiomyopathy), disruption of myofibrillary architecture and
myocardial dysfunction [1,2]. Although a number of scenarios
have been speculated towards the onset and progression of
ethanol-induced myopathic changes including direct cardiotoxicity
of ethanol and its metabolites [3], oxidative stress and accumu-
lation of fatty acid ethyl esters [4], the ultimate culprit factor(s)
behind alcohol-elicited cardiac damage remains elusive. Acetal-
dehyde, the primary metabolic product of ethanol, has drawn
some recent attentions as a candidate toxin for the onset and
development of alcoholic cardiomyopathy [5]. Data from our
laboratory have shown that acetaldehyde directly compromises
myocardial excitation-contraction coupling, sarco(endo)plasmic
reticulum (SR) Ca
2+ release and cardiac contractile function
[5–8]. Meanwhile, facilitated clearance of acetaldehyde via mito-
chondrial aldehyde dehydrogenase (ALDH-2) was shown to be
beneficial in alleviating acute and chronic ethanol exposure-
induced contractile dysfunction and/or myocardial hypertrophy
[9,10], further supporting the detrimental role of acetaldehyde in
alcohol-induced myocardial damage. Nonetheless, the precise
mechanism of action behind the acetaldehyde-induced unfavor-
able myocardial functional and morphological changes following
either acute or chronic ethanol exposure remains elusive. Given
that apoptosis and mitochondrial damage are commonly present
in response to ethanol challenge and are thought to play an
essential role in alcoholism-elicited organ damage and complica-
tions [9,11], our current study was designed to address the role of
mitochondrial function and apoptosis in ethanol-induced myocar-
dial dysfunction. Here we took advantage of the novel transgenic
mouse model generated in our labs with the cardiac-specific
overexpression of alcohol dehydrogenase (ADH), which mimics an
‘‘acetaldehyde overloaded’’ model of alcoholic cardiomyopathy
[12]. Myocardial mitochondrial damage was assessed using
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N2) accumulation and mitochondrial
membrane potential. Mitochondria are known to play a key role in
the maintenance of cardiac function and morphology through
regulation of reactive oxygen species production and apoptosis
[11]. Mitochondria are often themselves targets of oxidative stress
and contribute to mechanisms by which oxidative stress-related
cell signals control cardiac contractile function [11,13]. We further
examined the roles of the two main apoptotic domains including
one through activated death receptors in the cell surface (extrinsic
pathway) and another via signals originated within the cell
involving mitochondria as either an initiator or a magnifier
(intrinsic pathway) [14]. The death receptor pathway is usually
triggered by the linkage of specific ligands to membrane receptors
including tumor necrosis factor a (TNF-a) and Fas receptor [14].
To this end, expression of TNF-a, Fas, Fas ligand (FasL), Caspase-
8 and pro-caspase-8 was examined in wild-type FVB and ADH
hearts following acute ethanol challenge. To monitor the change
in mitochondrial death domain, cytosolic accumulation of pro-
caspase-9, cytochrome C and apoptosis inducing factor (AIF) was
examined. TUNEL assay and levels of the pro-apoptotic proteins
Bax and Caspase-3 as well as the anti-apoptotic protein Bcl-2 were
used as for overall assessment of apoptosis.
Materials and Methods
Experimental Animals and Acute Ethanol Exposure
All animal procedures were conducted in accordance with
humane animal care standards outlined in the NIH Guide for the
Care and Use of Experimental and were approved the University
of Wyoming Animal Care and Use Committee. Production of the
ADH transgenic mice was described in detail previously [15]. In
brief, using the albino Friend Virus-B type (FVB) mice, the cDNA
for murine class I ADH was inserted behind mouse a-myosin
heavy chain promoter to achieve cardiac-specific overexpression.
This cDNA was chosen because class I ADH is the most efficient
in the oxidation of ethanol. A second transgene with a cDNA
encoding tyrosinase was co-injected with ADH. This enzyme
produces coat color pigmentation in albino mice and was used to
conveniently identify transgenic animals. All mice were housed in
a temperature-controlled room under a 12 hr/12 hr-light/dark
and allowed access to tap water ad libitum. For acute ethanol
challenge, adult male FVB and ADH mice (4–6 month-old) were
injected intraperitoneally with ethanol (3 g/kg/d) for 3 consecu-
tive days prior to euthanasia under anesthesia (ketamine/xylazine:
3:1, 1.32 mg/kg, i.p.).
Assessment of Ethanol and Acetaldehyde Levels
Upon sacrifice under anesthesia, blood plasma was collected
and was stored in sealed vials at 280uC. Immediately before
analysis, the samples were warmed to 25uC. A 2 ml aliquot of the
headspace gas from each vial was removed through the septum on
the cap with a gas tight syringe and transferred to a 200 ml loop
injection system on a Hewlett-Packard 5890 gas chromatograph
(GC) equipped with a flame ionization detector. Ethanol,
acetaldehyde and other components were separated on a 9-meter
VOCOL capillary column (Supelco) with film with 1.8 mm
thickness and an inner diameter of 0.32 mm. The temperature
was held isothermally at 30uC, and the carrier gas was helium at a
flow rate of 1.8 ml/min. Under these conditions, separation of
acetaldehyde from ethanol and other compounds was complete in
one minute. Quantitation was achieved by calibrating the GC
peak areas against those from headspace samples of known ethanol
and acetaldehyde standards, over a similar concentration range as
the tissue samples in the same buffer [16].
Mouse Heart Perfusion
Isolated mouse hearts were retrogradely perfused with a Krebs-
Henseleit buffer containing 7 mM glucose, 0.4 mM oleate, 1% BSA
and a low fasting concentration of insulin (10 mU/ml). Hearts were
perfused at a constant flow of 4 ml/min (equal to an aortic pressure
of 80 cmH2O) at baseline for 60 min. A fluid-filled latex balloon
connected to a solid-state pressure transducer was inserted into the
left ventricle through a left atriotomy to measure pressure. LVDP,
the first derivative of LVDP (6 dP/dt) and heart rate were recorded
using a digital acquisition system at a balloon volume which resulted
in a baseline LV end-diastolic pressure of 5 mmHg [17].
Histological Examination
Following anesthesia, hearts were excised and immediately
placed in 10% neutral-buffered formalin at room temperature for
24 hrs after a brief rinse with PBS. The specimen were embedded
in paraffin, cut in 5 mm sections and stained with hematoxylin and
eosin (H&E). Cardiomyocyte cross-sectional areas were calculated
on a digital microscope (x400) using the Image J (version1.34S)
software [9].
Isolation of Murine Cardiomyocytes
After ketamine/xylazine sedation, hearts were removed and
perfused with Krebs-Henseleit bicarbonate (KHB) buffer contain-
ing (in mM): 118 NaCl, 4.7 KCl, 1.2 MgSO4, 1.2 KH2PO4,2 5
NaHCO3, 10 HEPES and 11.1 glucose. Hearts were digested with
Table 1. Biometric parameters of FVB and ADH mice challenged with ethanol.
Parameter FVB FVB-EtOH ADH ADH-EtOH
Body Weight (g) 26.860.9 26.260.8 28.360.9 28.660.9
Heart Weight (mg) 14066 130671 4 0 651 4 1 66
Heart/Body Weight (mg/g) 5.2360.16 4.9460.19 5.6960.18 4.9560.23
Liver Weight (g) 1.2660.08 1.3060.05 1.4060.05 1.3960.04
Liver/Body Weight (mg/g) 47.262.5 49.460.8 49.762.1 49.361.8
Kidney Weight (g) 0.3160.02 0.3360.02 0.3460.02 0.3760.04
Kidney/Body Weight (mg/g) 11.560.3 12.660.4 12.160.6 13.260.5
Blood Alcohol (mg/dl) Undetectable 59.3610.3* Undetectable 62.7621.5*
Cardiac Acetaldehyde Levels (nmol/mg) 0.8760.53 35.364.2* 0.6060.40 99.9612.0*,
#
Mean 6 SEM, n=12–15 mice per group, undetectable: ,2.5 mg/dl, *p,0.05 vs. FVB group,
#p,0.05 vs. FVB-EtOH group.
doi:10.1371/journal.pone.0008757.t001
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minced before being filtered. Myocyte yield was 50%–70% which
was not overtly affected by ADH or ethanol challenge [9].
MitoSOX Red Fluorescence Measurement of
Mitochondrial O2
N2
Cardiomyocytes from FVB and ADH mice with or without
ethanol treatment were loaded with MitoSOX Red (2 mM,
Molecular Probes) for 10 min. Maximum fluorescence uptake
interval was evaluated by preliminary experiments. After 1 hr’s
incubation at 37uC, cells were rinsed with the perfusion buffer and
MitoSOX Red fluorescence intensity was captured at 510/580 nm
using an Olympus BX51 microscope equipped with a digital cooled
charged-coupled device camera. InSpeck microspheres (Molecular
Probes) were used to calibrate MitoSOX Red fluorescence by
calculating the ratio of myocyte fluorescent intensities to the
fluorescent beads [18]. To assess the effect of the ethanol metabolite
acetaldehyde on mitochondrial O2
N2 generation, freshly isolated
cardiomyocytes from non-ethanol-treated FVB mice were incubat-
ed with acetaldehyde (100 mM) for 4 hrs at 37uC prior to
determination of the MitoSOX Red fluorescence.
Measurement of Mitochondrial Membrane Potential
Mitochondrial membrane potential (DYm) was detected in
cardiomyocytes suspended in a HEPES-saline buffer [19]. Briefly,
after a 10-min incubation with 5 mM JC-1 at 37uC, cells were
washed twice by sedimentation using HS buffer free of JC-1.
Cardiomyocytes were examined every 10 min for 120 min under
a confocal laser scanning microscope (Leica TCS SP2) at
excitation wavelength of 490 nm and the emission fluorescence
was recorded at 530 nm (monomer form of JC-1, green) and
590 nm (aggregate form of JC-1, red). Results in fluorescence
intensity were expressed as 590-to-530-nm emission ratio. The
mitochondrial uncoupler carbonyl cyanide m-chlorophenylhydra-
zone (CCCP, 10 mM) was used as a positive control for
mitochondrial membrane potential measurement [20].
TUNEL Staining
TUNEL (terminal deoxynucleotidyl transferase-mediated
dUTP nick-end labeling) assessment of myonuclei positive for
DNA strand breaks was determined using a fluorescence detection
kit (Roche Applied Science, Indianapolis, IN) and fluorescence
microscopy. After perfusion, mouse hearts were removed and fixed
in 4% paraformaldehyde overnight at room temperature. Cross
sections (5 mm) were placed in a cryostat (223uC) and fixed in 4%
paraformaldehyde 20 min and then fixed Sections were permea-
bilized with 0.1% Triton X-100 in 0.1% sodium citrate for 2 min
on ice. TUNEL reaction mixture containing terminal deoxynu-
cleotidyl transferase (TdT), fluorescein-dUTP was added to the
sections in 50-ml drops and incubated for 60 min at 37uCi na
humidified chamber in the dark. The sections were rinsed three
times in PBS for 5 min each. Following embedding, sections were
visualized with an Olympus BX-51 microscope equipped with an
Olympus MaguaFire SP digital camera. DNase I and label
solution were used as positive and negative controls. To determine
the percentage of apoptotic cells, the TUNEL-positive nuclei and
TUNEL-negative cells were counted using the ImagePro image
analysis software (Media Cybernetics, Bethesda, MD) [21].
Western Blot Analysis
The total and cytosolic fractions of protein were prepared as
described [9,22]. Samples containing equal amount of proteins
were separated on 10% SDS-polyacrylamide gels in a minigel
apparatus (Mini-PROTEAN II, Bio-Rad) and transferred to
nitrocellulose membranes. The membranes were blocked with
5% milk in TBS-T, and were incubated overnight at 4uC with
anti-ANP, anti-Bax, anti-Bcl-2, anti-caspase-3, anti-pro-caspase-8,
anti-pro-caspase-9, anti-TNFa, anti-Fas receptor, anti-Fas L, anti-
AIF, and anti-cytochrome C antibodies. After washing blots to
remove excessive primary antibody binding, blots were incubated
Figure1.Effectofethanolexposureoncardiacfunction:Effectof
acute ethanol exposure on cardiac contractile function using a
Langendorff perfusion system in FVB and ADH mice. A: Left
ventricular developing pressure (LVDP); B and C: Maximal velocity of
pressuredevelopment(+dP/dt)anddecline(2dP/dt). Mean6SEM,n=5–
10 hearts per group, * p,0.05 vs. FVB, # p,0.05 vs. FVB-EtOH group.
doi:10.1371/journal.pone.0008757.g001
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antibody (1:5,000). Antibody binding was detected using enhanced
chemiluminescence (Amersham Pharmacia, Piscataway, NJ), and
film was scanned and the intensity of immunoblot bands was
detected with a Bio-Rad Calibrated Densitometer (Model: GS-
800). All tissue samples were run in duplicates. a-Tubulin was used
as the loading control.
Data Analysis
Data are Mean 6 SEM. Difference was calculated by repeated
measures analysis of variance (ANOVA) followed by a Tukey’s post
hoc analysis. A p value,0.05 was considered significant.
Results
General Features and Whole Heart Function of FVB and
ADH Mice Treated with Alcohol
Neither ethanol treatment nor ADH transgene altered body and
organ weights or organ size (shown as the organ-to-body weight
ratio). As expected, acute ethanol exposure elicited comparable
elevations in blood alcohol level, which was minimal in the non-
ethanol-treated mice. Cardiac acetaldehyde levels were signifi-
cantly increased following ethanol challenge, the effect of which
was exacerbated by the ADH transgene (Table 1). Assessment of
whole heart function including LVDP, maximal velocity of
pressure development and decline (6 dP/dt) revealed a significant
decline following ethanol treatment, the effect of which was
accentuated by ADH (Fig. 1).
Effect of Acute Ethanol Exposure on Myocardial
Histology in FVB and ADH Mice
To assess the impact ADH on myocardial histology following
acute ethanol challenge, the cardiomyocyte cross-sectional area
was examined. In the H&E staining sections, acute ethanol
challenge increased the cardiomyocyte transverse cross-section
area. The ethanol-induced increase in cardiomyocyte cross-
sectional area was significantly augmented by the ADH transgene
(Fig. 2).
Figure 2. Histological analyses following ethanol exposure: Histological analyses hearts from FVB and ADH mice with or without
ethanol exposure. A - D: H&E staining micrographs of transverse sections of left ventricular myocardium (x 400) from FVB, FVB-EtOH, ADH and
ADH-EtOH groups; E: Quantitative analysis of cardiomyocyte cross-sectional (transverse) area using measurements of ,150 cardiomyocytes from 3–5
mice per group. Mean 6 SEM, * p,0.05 vs. FVB, # p,0.05 vs. FVB-EtOH group.
doi:10.1371/journal.pone.0008757.g002
ADH, Ethanol and Mitochondria
PLoS ONE | www.plosone.org 4 January 2010 | Volume 5 | Issue 1 | e8757Effect of Acute Ethanol Exposure on Mitochondrial O2
N2
Production and Membrane Potential
To evaluate mitochondrial integrity and function, mitochon-
drial O2
N2 production and membrane potential were detected
using the MitoSOX Red and JC-1 fluorescent probes, respectively.
Our data revealed that acute ethanol exposure significantly
promoted mitochondrial O2
N2 production and decreased mito-
chondrial membrane potential in cardiomyocytes, the effects of
which were accentuated by ADH. The ADH transgene itself did
not elicit any significant effect on mitochondrial O2
N2 production
or mitochondrial membrane potential (Fig. 3 and Fig. 4).
Moreover, the ADH enzymatic metabolite of ethanol, acetalde-
hyde (100 mM), significantly promoted mitochondrial O2
N2
production (Fig. 3F).
Effect of Acute Ethanol Exposure on Myocardial
Apoptosis in FVB and ADH Mice
Acute ethanol exposure is often associated with enhanced
apoptosis [9]. The acute ethanol challenge-elicited effect on
myocardial mitochondrial damage was further supported by
apoptotic assay using TUNEL staining. The TUNEL-positive
nuclei visualized in fluorescein green as a percentage of all nuclei
Figure 3. Mitochondrial O2
N2 generation following ethanol exposure: Mitochondrial O2
N2 generation using the MitoSOX Red probe
in cardiomyocytes from FVB and ADH mice with or without acute ethanol exposure. Cohorts of non-ethanol-treated FVB cardiomyocytes
were incubated with the ADH enzymatic metabolite of ethanol, acetaldehyde (ACA, 100 mM), for 4 hrs at 37uC prior to MitoSOX Red measurement.
A–E: Representative fluorescence images (40x) from FVB, FVB-EtOH, ADH, ADH-EtOH and FVB-ACA groups. F: Pooled data. Mean 6 SEM, n=15–20
fields per group, * p,0.05 vs. FVB, # p,0.05 vs. FVB-EtOH group.
doi:10.1371/journal.pone.0008757.g003
Figure 4. Mitochondrial function following ethanol exposure:
Cardiomyocyte mitochondrial membrane potential (MMP) in
FVB and ADH mice with or without acute ethanol exposure. JC-
1 fluorochrome was shown as the ratio of red to green fluorescence.
CCCP was used a positive control. Mean 6 SEM, n=9–14 cells per
group, * p,0.05 vs. FVB, # p,0.05 vs. FVB-EtOH group.
doi:10.1371/journal.pone.0008757.g004
ADH, Ethanol and Mitochondria
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from acute ethanol-treated FVB mice, the effect of which was
exacerbated by ADH. ADH transgene itself did not affect the
TUNEL-positive nuclei in the absence of ethanol exposure (Fig. 5).
Effect of Acute Ethanol Challenge on ANP and Apoptotic
Protein Makers in FVB and ADH Mice
Our data revealed that neither acute ethanol challenge nor
ADH transgene affected the hypertrophic marker ANP expression.
In line with the TUNEL assay observation, our further results
indicated that ethanol treatment significantly increased expression
of the pro-apoptotic proteins Bax and Caspase-3 while decreasing
the level of the anti-apoptotic protein Bcl-2. Although ADH failed
to alter the ethanol-induced response of Caspase-3, it significantly
augmented ethanol-elicited responses in Bax and Bcl-2. ADH
transgene itself did not elicit any effect on the expression of Bax,
Bcl-2 and Caspase-3 in the absence of ethanol treatment (Fig. 6).
We went on to examine the involvement of the death receptor and
mitochondrial death pathways in ADH and ethanol-associated
apoptotic effects. Neither ethanol nor ADH transgene affected the
levels of the main death receptor apoptotic proteins TNFa, Fas
receptor and Fas ligand (FasL) and Caspase-8 (Fig. 7). Examina-
tion of the mitochondrial death pathway depicted that acute
ethanol treatment significantly promoted cytosolic accumulation of
cytochrome C and pro-caspase-9, the effect of which was
augmented by ADH. Neither ethanol nor ADH altered the levels
of total pro-caspase-9, cytosolic AIF and the death receptor
mediator cytosolic pro-caspase-8 (Fig. 8).
Discussion
The hallmarks of alcoholic cardiomyopathy include compro-
mised cardiac morphology and myocardial contractility [1,2,5].
This is coincided with our observations of reduced myocardial
contraction and enlarged cardiomyocyte area in ethanol-chal-
lenged murine hearts. Furthermore, data from our present study
revealed overt mitochondrial damage and apoptosis following
ethanol challenge, which may contribute to the ethanol-elicited
myocardial histological and functional alterations. More strikingly,
our study provided evidence for the first time that cardiac
mitochondrial damage and apoptosis following ethanol exposure
may be exacerbated by overexpression of ADH, which produces
much more local acetaldehyde in the hearts consistent with the
previous findings [15,16]. These observations are in favor of the
notion that facilitated ethanol metabolism via ADH enzyme
exacerbates ethanol-induced myocardial dysfunction, histological
alteration and apoptosis possibly related to mitochondrial damage.
Data from our present study revealed that ADH accentuated
ethanol-induced cardiomyocyte hypertrophy with little change in
gross weight of the heart or expression of the hypertrophic marker
ANP. These seemingly conflicting data may be a concerted result
from hypertrophy and apoptosis in murine cardiomyocytes. An
earlier study using the same ADH transgenic mice noted overt
Figure 5. TUNEL staining following ethanol exposure: Photomicrograph showing TUNEL staining in cardiomyocytes from FVB and
ADH mice with or without acute ethanol treatment. TUNEL positive nuclei were visualized with fluorescein (green). A: FVB; C: FVB-EtOH; E:
ADH; and G: ADH-EtOH. All nuclei were stained with DAPI shown in blue color. B: FVB; D: FVB-EtOH; F: ADH; and H: ADH-EtOH. Pooled data are shown
in panel I. Mean 6 SEM, n=4–6 mice per group, * p,0.05 vs. FVB, # p,0.05 vs. FVB-EtOH group.
doi:10.1371/journal.pone.0008757.g005
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phic markers a-skeletal actin and atrial natriuretic factor in ADH
but not FVB mice after 10 weeks of alcohol feeding [23]. To this
end, it is not surprising for the lack of change in ANP in response
to acute ethanol challenge in our experimental settings. The
enlarged cardiomyocyte size may be a result of certain
hemodynamic changes following acute ethanol challenge or binge
drinking although further study is warranted. Acetaldehyde is
known to trigger both oxidative stress and apoptosis via activation
of stress signaling such as c-Jun phosphorylation [5,24,25]. This is
supported by our experimental findings of elevated O2
N2
production and TUNEL-positive apoptotic cells in ADH murine
hearts following ethanol challenge. Enhanced O2
N2 and oxidative
stress are known to induce hypertrophy in cardiomyocytes. As the
major metabolite of ethanol, acetaldehyde enhances free radical
generation through aldehyde oxidase and xanthine oxidase-
associated oxidation, leading to accumulation of O2
N2 as shown
in our present study [5,26–28]. Our earlier report indicated that
ADH produced greater levels of lipid peroxidation and protein
carbonyls in hearts from the alcohol-fed mice [16], indicating a
key role of free radical formation in alcohol- and acetaldehyde-
induced cardiac damage. To the contrary, the occurrence of
apoptosis contributes to the loss of cardiomyocytes, which is
deemed as a predictor of adverse outcomes for cardiac diseases
and eventually heart failure [29]. With the concurrent hypertro-
phy and loss of cell number in cardiomyocytes, it is not surprising
to find the unchanged gross heart weight in response to acute
ethanol exposure.
Mitochondrial integrity plays a pivotal role for cell survival and
function [11]. Loss of mitochondrial integrity leads to the
development of several diseases such as neurodegenerative
disorders, diabetesandischemiareperfusion-inducedheartdamage.
Recently, mitochondrial dysfunction also received some attentions
in the onset of alcoholic complications [11]. Data from our current
study revealed elevated mitochondrial O2
N2 production and
reduced mitochondrial membrane potential in hearts following
acute ethanol exposure. More intriguingly, the ethanol-induced
changes in mitochondrial membrane potential and mitochondrial
O2
N2 production were exaggerated by the ADH transgene (or
mimicked by the ethanol metabolite acetaldehyde). These observa-
tions were in line with the changes in myocardial contractility and
histology in both FVB and ADH mice following ethanol exposure,
suggesting the essential role of mitochondria in ADH-induced
exacerbation of myocardial injury in response to ethanol exposure.
Mitochondrial damage has been demonstrated to result in
apoptosis through mitochondrial pathways [11]. Apoptosis or
programmed cell death plays a key role in the pathogenesis of a
variety of diseases including atherosclerosis, myocardial ischemia
Figure 6. Cardiac hypertrophy and apoptosis following ethanol exposure: Expression of the hypertrophic marker ANP and
apoptosis-related proteins in myocardium from FVB and ADH mice with or without acute ethanol exposure. A: ANP; B: Bax; C: Bcl-2;
and D: Caspase-3. Insets: Representative gel blots depicting expression of ANP, Bax, Bcl-2, Caspase-3 and a-Tubulin (loading control). Mean 6 SEM,
n=5–10 samples per group, all samples were in duplicates with the average being used, * p,0.05 vs. FVB, # p,0.05 vs. FVB-EtOH group.
doi:10.1371/journal.pone.0008757.g006
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cardiomyopathy [30–33]. Apoptosis is closely associated with a
number of cardiovascular anomalies such as myocardial infarc-
tion, dilated cardiomyopathy, end-stage heart failure, ventricular
dysplasia, hypertrophic cardiomyopathy and ischemia reperfusion
injury in both patients and animal models [34–39]. As mentioned
earlier, two major defined pathways are involved in the apoptotic
signaling cascade in the heart namely the death receptor and
mitochondria pathways, both of which mainly depend on the
activation of caspase [40,41].
In this study, the decreased expression of Bcl-2, up-regulated
expression of caspase-3 and Bax, as well as increased TUNEL
positive cells depicted the presence of a global myocardial apoptosis
following acute ethanol exposure. Our observation of significantly
increased cytosolic expression of cytochrome C and pro-caspase-9
in ethanol-treated mice depicts an essential role of the mitochon-
drial death pathway in ethanol-induced apoptosis. The fact that the
ADH transgene augmented the ethanol-induced cytosolic accumu-
lation of pro-caspase-9 and cytochrome C further substantiated the
critical role of acetaldehyde in ethanol-induced mitochondrial
damage, which is consistent with the ADH-accentuated mitochon-
drial O2
N2 production and mitochondrial membrane potential loss
following acute ethanol challenge. It has been demonstrated that
pro-caspase-8 and pro-caspase-9 are predominantly localized in
mitochondria which are released into cytoplasm upon permeabi-
lization of the outer mitochondrial membrane upon apoptosis
stimulation or oxidative stress [42,43]. AIF, another important
factor normally localizes to the mitochondrial inter-membrane
space, plays a critical role in the caspase-independent apoptosis
[44]. Our finding of unaltered cytosolic AIF expression does not
seem to favor the involvement of a caspase-independent apoptotic
process in ethanol-induced cell death. It should be mentioned that
our results cannot directly address the intimate interplay between
mitochondrial damage and myocardial dysfunction in these mice
following acute ethanol exposure. Our current findings of
unchanged expression of TNF-a, Fas receptor, Fas L, caspase-8
and pro-caspase-8 in FVB and ADH mice in response to ethanol
exposure suggest a minimal role of the death receptor pathway in
ethanol-and ADH-elicited apoptotic responses.
In summary, the present study has provided convincing
evidence that cardiac overexpression of ADH exacerbated acute
ethanol exposure-induced myocardial contractile dysfunction
associated with mitochondrial damage and apoptosis, supporting
an essential role of acetaldehyde and mitochondrial dysfunction in
ethanol-elicit alcoholic myopathic alteration. Although it is still
premature to discern the precise contributions from various death
Figure 7. Death receptor pathway in myocardium following ethanol exposure: Expression of Caspase-8 (A), TNFa (B), Fas receptor
(C) and Fas Ligand (Fas L, D) in myocardium from FVB and ADH mice with or without acute ethanol exposure. Insets: Representative
gels using specific antibodies. Mean 6 SEM, n=3–6 samples per group, all samples were in duplicates with the average being used.
doi:10.1371/journal.pone.0008757.g007
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ethanol-induced cell death and tissue injury, our data should shed
some lights towards a better understanding of the role of
mitochondria and mitochondrial death pathway in alcohol-
induced myocardial dysfunction. Although certain mitochondria-
centered medicinal product (e.g., MacroMicro
TM Cleanse &
Detox) has been developed to improve mitochondrial function
against acetaldehyde-induced handover and other complications
following alcohol intake, further scrutiny is required to unveil the
clinical value of mitochondrial protection under the state of both
binge drinking and chronic alcoholism.
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